Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)

NCT01202864 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2017-09-01

No results posted yet for this study

Summary

The purpose of this study is to find risk factors for hemorrhagic stroke, specifically intracerebral hemorrhage (ICH), among Caucasians, African Americans, and Hispanics.

Conditions

  • Intracerebral Hemorrhage

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER
  • Columbia University

    collaborator OTHER
  • University of Maryland

    collaborator OTHER
  • Georgetown University

    collaborator OTHER
  • Wake Forest University

    collaborator OTHER
  • Emory University

    collaborator OTHER
  • University of Miami

    collaborator OTHER
  • University of Illinois at Chicago

    collaborator OTHER
  • University of Texas, Southwestern Medical Center at Dallas

    collaborator OTHER
  • The University of Texas Health Science Center, Houston

    collaborator OTHER
  • The University of Texas Health Science Center at San Antonio

    collaborator OTHER
  • University of New Mexico

    collaborator OTHER
  • University of Arizona

    collaborator OTHER
  • University of Southern California

    collaborator OTHER
  • St. Luke's-Roosevelt Hospital Center

    collaborator OTHER
  • University of California, San Francisco

    collaborator OTHER
  • Duke University

    collaborator OTHER
  • University of Virginia

    collaborator OTHER
  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH
  • University of Cincinnati

    lead OTHER

Principal Investigators

  • Daniel Woo, MD, MS · University of Cincinnati

  • Matthew Flaherty, MD · University of Cincinnati

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-01
Primary Completion
2017-07-31
Completion
2017-08-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01202864 on ClinicalTrials.gov